AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Snipd AI
Hollywood strike ends with potential increase in TV show production costs and fewer shows. Disney's acquisition of Hulu and its implications for streaming. Turning around a stock drop caused by false information. FDA approval of a weight loss drug and its impact on Eli Lilly. Impact of behavioral changes on stocks and stock picks for the week.
Read more
AI Summary
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- The film and TV industry strikes a deal with actors, allowing the content engine to start back up, but uncertainties remain about Hollywood's spending habits.
- Axon, a producer of Tasers and body cameras, has shown resilience by achieving strong revenue growth and international expansion despite challenging market conditions.
Deep dives
Eli Lilly's Zepbound weight loss drug approved by FDA
The FDA has approved Eli Lilly's weight loss drug, Zepbound, for chronic weight management. The drug targets appetite and is approved to be used in conjunction with a calorie deficit and exercise. However, it is important to note that weight loss drugs should not be seen as a cure-all, but rather as part of a holistic weight loss strategy.
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode